肺癌不同治疗模式生存比较
时间:2020-03-02 23:57来源:未知 作者:admin
Alla Y. Zemlyak, MD Comparison of survival after sublobar resections and ablative therapies for stage I NSCLC Primary end points overall survival, cancer-specific survival, and cancer-free survival N=25 SLR N=12 RFA N=27 Cryo N= CECT, FDG
Alla Y. Zemlyak, MD
Comparison of survival after sublobar resections and ablative therapies for stage I NSCLC
• Primary end points overall survival, cancer-specific survival, and cancer-free survival
• N=25 SLR
• N=12 RFA
• N=27 Cryo
• N= CECT, FDG PET/CT follow-up
Zemlyak et al. J Am Coll Surg. 2010 ;211:68-72
KM survival probabilities after sublobar resections and ablative therapies for stage I non-small cell lung cancer
PCT = percutaneous cryablation therapy
Zemlyak et al. J Am Coll Surg. 2010 ;211:68-72 |
------分隔线----------------------------
